Verastem | VSTM - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
AbbVie USD 4.22B 329M 2026-03
Alaunos Therapeutics USD 0 18K 2024-09
AstraZeneca USD -204M 3.48B 2026-03
Curis USD 314K 9.96M 2025-12
Cytokinetics USD 160K 104.24M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
TG Therapeutics USD 33.51M 4.63M 2026-03
Verastem USD 2.89M 2.88M 2025-12